Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCombined Modality TherapyCisplatinDoxorubicinCyclophosphamideTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideSurvival AnalysisNeoplasm StagingLung NeoplasmsPrognosisSurvival RateDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineDrug Resistance, NeoplasmNeoplasmsNeoplasm Recurrence, LocalTaxoidsTime FactorsIfosfamideBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticDose-Response Relationship, DrugCell Line, TumorAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungFollow-Up StudiesAdenocarcinomaOvarian NeoplasmsNeoplasm MetastasisAntibiotics, AntineoplasticTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseApoptosisBrain NeoplasmsColorectal NeoplasmsRadiotherapyCells, CulturedDacarbazineLiver NeoplasmsClinical Trials as TopicProspective StudiesNeoplasms, Germ Cell and EmbryonalCarmustineImmunohistochemistryLomustineGranulocyte Colony-Stimulating FactorCamptothecinKaplan-Meier EstimatePlatinum CompoundsBone NeoplasmsAntibodies, MonoclonalInfusions, Intra-ArterialOsteosarcomaMelphalanLeukopeniaAntiemeticsMitomycinCarcinomaDisease ProgressionThiotepaTumor Markers, BiologicalHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsMitoxantroneInfusions, IntravenousLymphatic MetastasisCell ProliferationRecurrenceStomach NeoplasmsTegafurPalliative CareAntibodies, Monoclonal, HumanizedGerminomaRadiotherapy DosageCell SurvivalDaunorubicin